or
forgot password

    • cancer clinical trials in merrick, NY

    • Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Long Island Gastroenterology Group, P.C.
    Merrick, New York 11566
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    Long Island Gastroenterology Group, P.C.
    Merrick, New York 11566
    Ulcerative Colitis